Categories: NewsNutrition

Serena H. Chen, MD, Joins the Theralogix Medical Advisory Board

Dr. Chen’s expertise and notable achievements help reinforce the company’s commitment to science and evidence-backed supplements.

ROCKVILLE, MD / ACCESSWIRE / August 30, 2023 / Theralogix, a national leader in the supplement industry, announces the addition of Serena H. Chen, MD, to its esteemed Medical Advisory Board. Dr. Chen’s numerous credentials and extensive experience in the field of reproductive medicine make her a valuable asset to the board.

Serena H. Chen, MD, graduated from Brown University and earned her MD at Duke University School of Medicine. She trained in Gynecology, Obstetrics, Reproductive Endocrinology & Infertility at The Johns Hopkins Hospital and now holds multiple distinguished titles including Director for the Division of Reproductive Medicine at Cooperman Barnabas Medical Center, Chief Advocacy Officer at CCRM NJ, and a Founder and Vice President of Doctors for Fertility NFP.

Dr. Chen strongly supports her patients’ right to be informed and involved in their own care, and she is passionate about access to fertility treatment for all. In 2020, Dr. Chen was the recipient of Resolve’s prestigious Hope Award, recognizing her advocacy for legislation that ensures access to care for those diagnosed with infertility.

Theralogix was founded on science and the commitment that every product has extensive research to back it up. Theralogix’s Medical Advisory Board (MAB) plays a vital role in solidifying this dedication to science-backed products. Made up of a carefully selected group of physicians, top research scientists, and faculty members at leading U.S. medical schools, the MAB evaluates and approves new product formulations, while offering guidance to improve existing ones.

Theralogix sets the standard for premium, research-backed nutritional supplements. Each product in their full line of supplements is independently certified by NSF® International for content accuracy and freedom from contaminants. Theralogix has been a top physician-recommended brand for over two decades. For more information about Theralogix and its range of evidence-based products, please visit the Theralogix website.

Contact Information

Shannon Mahon
smahon@theralogix.com
301.464.7210

SOURCE: Theralogix

View source version on accesswire.com:
https://www.accesswire.com/778150/Serena-H-Chen-MD-Joins-the-Theralogix-Medical-Advisory-Board

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

9 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

12 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

12 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

12 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

12 hours ago